Given that SMAD7 is involved in intestinal inflammation through its regulation of TGF-β signaling [22], [23] the association between SMAD7 SNPs and CRC risk may be modified by factors affecting inflammation. This evidence concerns the gene TGFB1 and colorectal carcinoma.